An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Clinical trial NCT00379795 · COMPLETED

Trial details

NCT number: NCT00379795
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Choroidal Neovascularization, Age-related Macular Degeneration

Start date: 2005-04-01
Primary completion: 2008-09-01
Enrollment: 853

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.